Search

everythinglearnresearchcommunity

for

Search:↓

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Early detection and targeted management are crucial for better outcomes in systemic lupus erythematosus.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

MicroRNA-21 could help diagnose and treat skin fibrosis.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Genetic differences affect COVID-19 severity and treatment development.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.